You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LEE011

Showing 1 - 25 of 1,376
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Trial in Hong Kong, Japan, Singapore (LEE011, Letrozole,

Completed
  • Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
  • LEE011
  • +4 more
  • Hong Kong, Hong Kong
  • +14 more
Oct 25, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Lymphoma, Solid Tumor Trial in Buffalo (Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)

Terminated
  • Lymphoma
  • Solid Neoplasm
  • Gemcitabine Hydrochloride
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)

Completed
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
Jan 11, 2023

Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)

Active, not recruiting
  • Breast Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Aug 16, 2022

Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer

Terminated
  • Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022

Triple Negative Breast Cancer Trial in United States (ribociclib, Bicalutamide)

Recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
  • +5 more
Oct 31, 2022

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Advanced Breast Cancer Trial in Philadelphia (Ribociclib (LEE011), Paclitaxel)

Active, not recruiting
  • Advanced Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 28, 2021

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Little Rock, Arkansas
  • +12 more
Sep 24, 2022

Glioblastoma Multiforme, Meningioma Trial in Phoenix (Ribociclib)

Recruiting
  • Glioblastoma Multiforme
  • Meningioma
  • Phoenix, Arizona
    Barrow Brain and Spine
Oct 7, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (ribociclib, Paclitaxel, Carboplatin)

Completed
  • Ovarian Cancer
  • +2 more
  • Ann Arbor, Michigan
  • +7 more
Sep 1, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Phoenix, Jacksonville, Rochester (Gemcitabine

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Gemcitabine Hydrochloride
  • +3 more
  • Phoenix, Arizona
  • +2 more
Oct 6, 2021

Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

Active, not recruiting
  • Breast Cancer
  • LEE011
  • +2 more
  • San Diego, California
  • +23 more
Feb 17, 2022

Breast Cancer Trial in Boston, Danvers (Ribociclib, Endocrine therapy)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Jan 6, 2023

Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

Terminated
  • Neuroblastoma
  • Cancer
  • Biopsy
  • +12 more
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jan 31, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Breast Cancer Trial (Ribociclib)

No longer available
  • Breast Cancer
  • (no location specified)
Feb 15, 2022

Hepatocellular Carcinoma Trial in Dallas (LEE011, Chemoembolization)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • LEE011
  • Chemoembolization
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 28, 2021